RHEUMATOID ARTHRITIS SEVERITY INDEX AND ITS RELATION TO COMORBIDITY IN EGYPTIAN RHEUMATOID ARTHRITIS PATIENTS.

  • Rheumatology and Rehabilitation Department, Faculty of Medicine, Zagazig University, Egypt.
  • Department of Community, Environmental and Occupational Medicine, Faculty of Medicine, Zagazig University, Egypt.
  • Department of Public Health and Preventive Medicine, Faculty of Medicine, Zagazig University, Egypt.
Crossref Cited-by Linking logo

  • Abstract
  • References
  • How to Cite This Article
  • Corresponding Author

Objective: This study aimed to apply the previously validated Rheumatoid arthritis medical records-based index of severity index (RARBIS) to RA patients in Egyptians and its relation to Comorbidity. Method: Data of RA patients retrospectively collected from medical records in the follow up unit of the Rheumatology and Rehabilitation Department of Zagazig University hospital.The data were collected as regarding socio-demographic and clinical characteristics of the studied RA patients,the collected data were computerized and statistically analyzed using SPSS programversion 20.0 Results: A total of 1142 patients files were reviewed and included in the study, their ages ranged from (20-73) years and the duration of the RA disease ranged from (1-20) years. We found that the total (RARBIS) score ranged from 3-16 with a mean of 8.09 ? 2.41.Also, the most frequent comorbidities in our patients are osteoporosis, hypertension, and peptic ulcer. RARBIS total score was high significant statistically increased in RA patients with comorbidities compared to those without comorbidities. In addition, the mean age of RA patients, rural area residency and illiteracy, increasing disease duration, prescribed NSAIDs or prednisolone were associated with high frequency increase in RA comorbidities. It was found that no significant difference when comparing frequency of comorbidities with sex, smoking and working status. Conclusion: Our study demonstrated that the Egyptian RA patients have relatively high scores of severity index, and most of patients with severe RA suffer from a number of associated comorbidities withsignificant relationship with the severity index.

  1. Gabriel S, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and co-morbidity of the rheumatic diseases. Arthritis Res Ther. 2009; 11:229.
  2. Osiri M, Maetzel A. The economic burden of rheumatoid arthritis: Asia/Thailand perspective. In: Preedy VR, Watson RR, editors. Handbook of disease burdens and quality of life measures. New York: Springer Science + Business Media; 2010. p. 1733?50.
  3. Kvien TK. Epidemiology and burden of illness of rheumatoid arthritis. Pharmaco-economics 2004; 22:1?12.
  4. Osiri M1 and Sattayasomboon Y.: Prevalence and out-patient medical costs of comorbid conditions in patients with rheumatoid arthritis. Joint Bone Spine.2013 Dec; 80(6):608-612.
  5. Gabriel SE.: Why do people with rheumatoid arthritis still die prematurely? Ann Rheum Dis. 2008; 67(3):iii30?34.
  6. Furst D., Chang H., Greenberg J., et al.: Prevalence of low hemoglobin levels andassociations with other disease parameters in rheumatoid arthritis patients:evidence from the CORRONA registry. ClinExpRheumatol 2009; 27:560?6.
  7. Ikwer M., Bergstrom U., Nilsson J., et al.: Early menopause is an independent predictor of rheumatoid arthritis. Ann Rheum Dis. 2012;71(3):378?81.
  8. Cabral D., Katz J., Weinblatt M., et al.:Development and assessment of indicators of rheumatoidarthritis severity: results of a Delphi panel. Arthritis Rheum 2005; 53:61-66.
  9. Siebert S., Lyall D., Mackay D., et al.: Characteristics of rheumatoid arthritis and its association with major comorbid conditions: cross-sectional study of RMD Open.2016; 2(1):e000267. doi: 10.1136/rmdopen-2016-000267.
  10. Dougados M.,Soubrier M., Antunez A. and Balintet P, et al.:. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA) Ann Rheum Dis 2014;73:62?68.
  11. Ikuyama S, Imamura-Takase E, Tokunaga S, Oribe M, Nishimura J. Sixty percent of patients with rheumatoid arthritis in Japan have used dietary supplements or health foods. Mod Rheumatol. 2009;19(3):253?9.
  12. Sineglazova AV, Kalev OF, Trushin IV, Rostovtsev MV. Special features of coronary artery involvement in women with rheumatoid arthritis. Kardiologiia. 2012; 52(8):44?7.
  13. El-Zorkany B&Mokbel A and Gamal S., et al: Comparison of comorbidities of the Egyptian rheumatoid arthritis patients to the global cohort of the COMORA study:a post-hoc analysis.ClinRheumatol (2016) 35:1153?1159
  14. Briggs AM, March L, Lassere M, et al. Baseline comorbidities in a population-based cohort of rheumatoid arthritis patients receiving biological therapy: data from the Australian Rheumatology Association database. Int J Rheumatol2009; 2009:861481.
  15. Al-Bishri J, Attar S, Bassuni N, Al-Nofaiey Y, et al: Comorbidity Profile Among Patients with Rheumatoid Arthritis and the Impact on Prescriptions TrendClinical Medicine Insights: Arthritis and Musculoskeletal Disorders 2013;6: 11?18.
  16. Sato M., Schneeweiss S., Scranton R., et al.: The validity of a rheumatoid arthritis medical records-based index of severity compared with the DAS28.Arthritis Research & Therapy; 2006, 8:R57 (doi:10.1186/ar1921)
  17. El Zorkany B, Alwahshi HA, Hammoudeh M et al (2013): Suboptimal management of rheumatoid arthritis in the Middle East and Africa: could the EULAR recommendations be the start of a solution? ClinRheumatol; 32(2):151?159.
  18. Van Hoogmoed D., Fransen J., Bleijenberg G., et al.: Physical and psychosocial correlates of severe fatigue in rheumatoid arthritis. Rheumatology (Oxford) 2010;49:1294?302. doi:10.1093/rheumatology/keq043.
  19. Matcham F., Rayner L., Steer S., et al.: The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford). 2013;52:2136?48.
  20. Espi?o-Lorenzo P., Manrique-Arija S, Ure?a I, et al.: Baseline comorbidities in patients with rheumatoid arthritis who have been prescribed biological therapy: a case control study. 2013 Jan-Feb;9(1):18-23.
  21. Navarro-Cano G., delRinco?n I., Pogosian S., et al.: Association of Mortality With Disease Severity in Rheumatoid Arthritis, Independent of Comorbidity. ARTHRITIS & RHEUMATISM; 2003, 48( 9): 2425?2433

Samah M. Alian, Rabab S. Zaghlol, Sahar S. Khalil, Dalia A. El-Shafei, Samah S. Sheta and Marwa B. Awad Allah. (2017); RHEUMATOID ARTHRITIS SEVERITY INDEX AND ITS RELATION TO COMORBIDITY IN EGYPTIAN RHEUMATOID ARTHRITIS PATIENTS., Int. J. of Adv. Res., 5 (03), 1443-1451, ISSN 2320-5407. DOI URL: https://dx.doi.org/10.21474/IJAR01/3651

Samah Mahmoud Alyan
Lecturer at Zagazig university , Zagazig, Egypt

DOI:

Article DOI: 10.21474/IJAR01/3651      
DOI URL: https://dx.doi.org/10.21474/IJAR01/3651

Download Full Paper

Download PDF No. of Downloads: 45 | No. of Views: 226